Research ArticleArticle
Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study
Maria A.C. van der Weijden, J. Christiaan van Denderen, Willem F. Lems, Michael T. Nurmohamed, Ben A.C. Dijkmans and Irene E. van der Horst-Bruinsma
The Journal of Rheumatology February 2016, jrheum.150857; DOI: https://doi.org/10.3899/jrheum.150857
Maria A.C. van der Weijden
From the Department of Rheumatology, VU University Medical Center; Department of Rheumatology, Jan van Breemen Research Institute/Reade, Amsterdam, the Netherlands. This investigator-initiated cohort study was financed by an unrestricted grant from Pfizer. M.A. van der Weijden, MD, MSc, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; J.C. van Denderen, MD, PhD, Department of Rheumatology, Jan van Breemen Research Institute/Reade; W.F. Lems, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; M.T. Nurmohamed, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; B.A. Dijkmans, MD, Professor, Department of Rheumatology, VU University Medical Center; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade. Address correspondence to Dr. M.A. van der Weijden, Department of Rheumatology, VU University Medical Center, Room 3A-54, P.O. Box 7057, 1007 MB Amsterdam, the Netherlands. E-mail: mac.vanderweijden@vumc.nl. Accepted for publication December 15, 2015.
J. Christiaan van Denderen
From the Department of Rheumatology, VU University Medical Center; Department of Rheumatology, Jan van Breemen Research Institute/Reade, Amsterdam, the Netherlands. This investigator-initiated cohort study was financed by an unrestricted grant from Pfizer. M.A. van der Weijden, MD, MSc, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; J.C. van Denderen, MD, PhD, Department of Rheumatology, Jan van Breemen Research Institute/Reade; W.F. Lems, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; M.T. Nurmohamed, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; B.A. Dijkmans, MD, Professor, Department of Rheumatology, VU University Medical Center; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade. Address correspondence to Dr. M.A. van der Weijden, Department of Rheumatology, VU University Medical Center, Room 3A-54, P.O. Box 7057, 1007 MB Amsterdam, the Netherlands. E-mail: mac.vanderweijden@vumc.nl. Accepted for publication December 15, 2015.
Willem F. Lems
From the Department of Rheumatology, VU University Medical Center; Department of Rheumatology, Jan van Breemen Research Institute/Reade, Amsterdam, the Netherlands. This investigator-initiated cohort study was financed by an unrestricted grant from Pfizer. M.A. van der Weijden, MD, MSc, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; J.C. van Denderen, MD, PhD, Department of Rheumatology, Jan van Breemen Research Institute/Reade; W.F. Lems, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; M.T. Nurmohamed, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; B.A. Dijkmans, MD, Professor, Department of Rheumatology, VU University Medical Center; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade. Address correspondence to Dr. M.A. van der Weijden, Department of Rheumatology, VU University Medical Center, Room 3A-54, P.O. Box 7057, 1007 MB Amsterdam, the Netherlands. E-mail: mac.vanderweijden@vumc.nl. Accepted for publication December 15, 2015.
Michael T. Nurmohamed
From the Department of Rheumatology, VU University Medical Center; Department of Rheumatology, Jan van Breemen Research Institute/Reade, Amsterdam, the Netherlands. This investigator-initiated cohort study was financed by an unrestricted grant from Pfizer. M.A. van der Weijden, MD, MSc, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; J.C. van Denderen, MD, PhD, Department of Rheumatology, Jan van Breemen Research Institute/Reade; W.F. Lems, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; M.T. Nurmohamed, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; B.A. Dijkmans, MD, Professor, Department of Rheumatology, VU University Medical Center; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade. Address correspondence to Dr. M.A. van der Weijden, Department of Rheumatology, VU University Medical Center, Room 3A-54, P.O. Box 7057, 1007 MB Amsterdam, the Netherlands. E-mail: mac.vanderweijden@vumc.nl. Accepted for publication December 15, 2015.
Ben A.C. Dijkmans
From the Department of Rheumatology, VU University Medical Center; Department of Rheumatology, Jan van Breemen Research Institute/Reade, Amsterdam, the Netherlands. This investigator-initiated cohort study was financed by an unrestricted grant from Pfizer. M.A. van der Weijden, MD, MSc, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; J.C. van Denderen, MD, PhD, Department of Rheumatology, Jan van Breemen Research Institute/Reade; W.F. Lems, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; M.T. Nurmohamed, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; B.A. Dijkmans, MD, Professor, Department of Rheumatology, VU University Medical Center; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade. Address correspondence to Dr. M.A. van der Weijden, Department of Rheumatology, VU University Medical Center, Room 3A-54, P.O. Box 7057, 1007 MB Amsterdam, the Netherlands. E-mail: mac.vanderweijden@vumc.nl. Accepted for publication December 15, 2015.
Irene E. van der Horst-Bruinsma
From the Department of Rheumatology, VU University Medical Center; Department of Rheumatology, Jan van Breemen Research Institute/Reade, Amsterdam, the Netherlands. This investigator-initiated cohort study was financed by an unrestricted grant from Pfizer. M.A. van der Weijden, MD, MSc, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; J.C. van Denderen, MD, PhD, Department of Rheumatology, Jan van Breemen Research Institute/Reade; W.F. Lems, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; M.T. Nurmohamed, MD, Professor, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade; B.A. Dijkmans, MD, Professor, Department of Rheumatology, VU University Medical Center; I.E. van der Horst-Bruinsma, MD, PhD, Department of Rheumatology, VU University Medical Center, and Department of Rheumatology, Jan van Breemen Research Institute/Reade. Address correspondence to Dr. M.A. van der Weijden, Department of Rheumatology, VU University Medical Center, Room 3A-54, P.O. Box 7057, 1007 MB Amsterdam, the Netherlands. E-mail: mac.vanderweijden@vumc.nl. Accepted for publication December 15, 2015.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study
Maria A.C. van der Weijden, J. Christiaan van Denderen, Willem F. Lems, Michael T. Nurmohamed, Ben A.C. Dijkmans, Irene E. van der Horst-Bruinsma
The Journal of Rheumatology Feb 2016, jrheum.150857; DOI: 10.3899/jrheum.150857
Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study
Maria A.C. van der Weijden, J. Christiaan van Denderen, Willem F. Lems, Michael T. Nurmohamed, Ben A.C. Dijkmans, Irene E. van der Horst-Bruinsma
The Journal of Rheumatology Feb 2016, jrheum.150857; DOI: 10.3899/jrheum.150857